Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

Funding reportedLast round: Series B

BiotechnologySan Diego, United States

What company datasets say Human Longevity raised

Funding, as reported

Reported in all$40Min dollars

Last roundSeries B

Investors listed5

SEC Form D$69M sold, 4 filings, last Aug 2024

From Human Longevity's own website: 2 on the team.

AdvisersRadiology Genomics

Investors who name them

Each firm lists Human Longevity on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Human Longevity in front of investors. Or tell us what we have wrong.